SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 18th, 2022 • Biovie Inc. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of July 15, 2022, between BioVie Inc., a Nevada corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
SERIES 2022-I COMMON STOCK PURCHASE WARRANT BioVie Inc.Security Agreement • July 18th, 2022 • Biovie Inc. • Pharmaceutical preparations
THIS SERIES 2022-I COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Acuitas Group Holdings, LLC or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after ______, 2022 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on _______ (the “Termination Date”) but not thereafter, to subscribe for and purchase from BioVie Inc., a Nevada corporation (the “Company”), up to 7,272,728 shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
